↓ Skip to main content

Dove Medical Press

Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor

Overview of attention for article published in Therapeutics and Clinical Risk Management, August 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

blogs
1 blog

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
15 Mendeley